Food News and Research

RSS

Watson Laboratories files an ANDA for generic version of Rozerem

Watson Pharmaceuticals, Inc., a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market its 8mg ramelteon tablets prior to the expiration of a patent owned by Takeda Pharmaceutical Company Limited.

4 Dec 2009

Allos Therapeutics, Idis collaborate in named patient program for FOLOTYN

Allos Therapeutics, Inc. today announced the execution of a collaborative agreement with Idis, a UK-based global company, to manage the named patient program for FOLOTYN™ (pralatrexate injection) outside of the United States. The U.S. Food and Drug Administration (FDA) has granted accelerated approval for FOLOTYN for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).

4 Dec 2009

FDA approves St. Jude Medical's Penta surgical lead for neurostimulation therapy

St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta™ surgical lead for neurostimulation therapy. Unveiled at the annual North American Neuromodulation Society meeting, the Penta lead is the first of its kind, featuring the smallest electrodes in the market arranged in five columns.

4 Dec 2009

FDA approves once-daily SEROQUEL XR Extended Release Tablets

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as adjunctive (add-on) treatment to antidepressants in adults with Major Depressive Disorder (MDD).

4 Dec 2009

FDA clears TSO3's STERIZONE 125L Sterilizer for expanded use

TSO3 Inc., an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that the Company has received clearance from the US Food and Drug Administration to expand the intended use claims for its TSO3 STERIZONE(R) 125L Sterilizer.

4 Dec 2009

Amgen/GSK's Prolia will be preferred as second- or third-line therapy for osteoporosis

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority of surveyed clinicians say they will use Amgen/GlaxoSmithKline's Prolia as either a second- or third-line therapy for osteoporosis if the drug receives regulatory approval for the indication.

4 Dec 2009

Concern about food safety: Latest cover story topic of C&EN weekly newsmagazine

Recalls of ground beef, peanut butter, and other foods have done more than raise public awareness and concern about food safety. They also are quietly fueling a boom in the market for food testing equipment and fostering new food safety regulations. That's the topic of the two-part cover story in the current issue of Chemical & Engineering News, (C&EN) ACS' weekly newsmagazine.

4 Dec 2009

APCER Pharma Solutions' webinar on 2010 FDA drug safety and pharmacovigilance initiatives

APCER Pharma Solutions, Inc.’s webinar on 2010 FDA drug safety and pharmacovigilance initiatives gave more than 250 professionals in the life sciences-related industries the jump start they needed to prepare for important changes next year.

4 Dec 2009

New SPC3649 drug found effective in treating HCV infections

In a dramatic finding, a new drug for hepatitis C virus (HCV) infections that targets liver cells produced a substantial drop in blood levels of the virus in animals and continued to work up to several months after treatment, say scientists at the Southwest Foundation for Biomedical Research (SFBR) in San Antonio.

4 Dec 2009

FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

St. Jude Medical, Inc. today announced U.S. Food and Drug Administration (FDA) approval of its next-generation MultiSteering Technology software for Rapid Programmer™, a programming platform used to optimize neurostimulation therapy for chronic pain patients.

4 Dec 2009

CEBP journal emphasizes on the most up-to-date research of tobacco use

The study of tobacco has been the life-long focus of his research and now, Peter Shields, MD, deputy director of the Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, has led the effort to edit a special-edition of Cancer Epidemiology, Biomarkers & Prevention (CEBP) dedicated to best research practices in tobacco science from researchers the world over.

4 Dec 2009

InVivo Therapeutics files an Investigational Device Exemption application with the FDA

InVivo Therapeutics Corporation has filed an Investigational Device Exemption application with the Food and Drug Administration requesting permission to advance to human clinical studies. InVivo is currently conducting its third primate study and expects to receive approval to begin a human study in 2010.

4 Dec 2009

KFDA approves RPC's Onko-Sure in Vitro Diagnostic cancer test

US-based pharmaceutical company Radient Pharmaceuticals Corporation (RPC) announced today the Korean Food & Drug Administration (KFDA) has approved RPC's Onko-Sure™ in Vitro Diagnostic cancer test for routine clinical testing and government reimbursement throughout Korea.

4 Dec 2009

Low energy diet improves obstructive sleep apnoea in obese men

Weight loss reduces obstructive sleep apnoea in obese men, with the greatest effect seen in patients with severe disease, according to new research published on bmj.com today.

4 Dec 2009

General Mills' new website provides information on gluten-free products

General Mills has created liveglutenfreely.com to provide consumers with information on gluten-free products and gluten-free recipes. The site lists General Mills products labeled gluten-free and features kitchen-tested recipes for preparing an array of gluten-free foods.

4 Dec 2009

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

After two decades of scientifically and medically proven success in their field, Lightlake Therapeutics' experts have been granted ethical approval to begin selecting and gene testing subjects for a trial of a simple, safe and effective treatment for what the World Health Organisation has described as a global epidemic of unhealthy eating and obesity.

3 Dec 2009

AP/Businessweek examines efforts to sell low-cost, portable toilets in developing world

The Associated Press/BusinessWeek examines the Singapore-based company Rigel Technology's efforts to sell "state-of-the-art portable, fertilizer-making, toilets for as low as $30" in developing countries. "Experts estimate about 2.5 billion people lack functioning, hygienic toilets and instead excrete in the open, a habit that can contaminate water supplies and spread diseases such as E. coli bacteria and other viruses," the publication writes.

3 Dec 2009

Also in global health news: U.S. aid to Philippines, Swaziland, Guyana; Uganda Bills; Botswana HIV/AIDS

U.S. Ambassador to the Philippines Kristie Kenney said the U.S. will give the country an additional $10 million worth of food aid for people affect by the recent typhoons, the Manila Bulletin reports. This brings "the total amount of its disaster relief and recovery assistance to US$30 million" (Sabater, 12/3).

3 Dec 2009

NIH approves new stem cell lines for research

The National Institutes of Health announced approval of embryonic stem cell lines for federally funded research. The Washington Post reports the decision is "opening the way for millions of taxpayer dollars to be used to conduct research that was put off-limits by President George W. Bush.

3 Dec 2009

Spectranetics receives FDA clearance for its new VisiSheath Dilator Sheath device

Spectranetics Corporation today announced it has received Food and Drug Administration (FDA) 510(k) clearance for its new VisiSheathTM Dilator Sheath device. This expands the market for VisiSheath, which recently also received CE Mark approval in Europe.

3 Dec 2009

Food News and Research

Watson Laboratories files an ANDA for generic version of Rozerem

Allos Therapeutics, Idis collaborate in named patient program for FOLOTYN

FDA approves St. Jude Medical's Penta surgical lead for neurostimulation therapy

FDA approves once-daily SEROQUEL XR Extended Release Tablets

FDA clears TSO3's STERIZONE 125L Sterilizer for expanded use

Amgen/GSK's Prolia will be preferred as second- or third-line therapy for osteoporosis

Concern about food safety: Latest cover story topic of C&EN weekly newsmagazine

APCER Pharma Solutions' webinar on 2010 FDA drug safety and pharmacovigilance initiatives

New SPC3649 drug found effective in treating HCV infections

FDA approves St. Jude Medical's MultiSteering Technology software for optimizing neurostimulation therapy

CEBP journal emphasizes on the most up-to-date research of tobacco use

InVivo Therapeutics files an Investigational Device Exemption application with the FDA

KFDA approves RPC's Onko-Sure in Vitro Diagnostic cancer test

Low energy diet improves obstructive sleep apnoea in obese men

General Mills' new website provides information on gluten-free products

Lightlake Therapeutics granted ethical approval for gene testing subjects in obesity treatment trial

AP/Businessweek examines efforts to sell low-cost, portable toilets in developing world

Also in global health news: U.S. aid to Philippines, Swaziland, Guyana; Uganda Bills; Botswana HIV/AIDS

NIH approves new stem cell lines for research

Spectranetics receives FDA clearance for its new VisiSheath Dilator Sheath device

The future is bioengineered: Synthetic biology and global sustainability eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News